Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants

Clinical Orthopaedics and Related Research

Volumn 329, Issue SUPPL., 1996, Pages

  Case, Charles Patrick ^a   Langkamer, Victor George ^b   Howell, Rodney Thomas ^b   Webb, Jacky ^b   Standen, Graham ^b   Palmer, Martin ^b   Kemp, Anthony ^b   Learmonth, Ian Douglas ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN HEAVY CHAIN; PARAPROTEIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CANCER RISK; CARCINOGENICITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; GOOD LABORATORY PRACTICE; HUMAN; HUMAN TISSUE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRECANCER; PRIORITY JOURNAL; PROSTHESIS LOOSENING; TOTAL HIP PROSTHESIS;

EID: 0029813581     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199608001-00024     Document Type: Article

References (33)

1. Case CP, Langkamer VG, James C, et al: Widespread dissemination of metal debris from implants. J Bone Joint Surg 76B:701-712, 1994.
2. Coleman MP: Cancer risk from orthopaedic prostheses. Ann Clin Lab Sci 1996. (In press)
3. Culligan DF, Cachia P, Whittaker J, Jacobs A, Padua RA: Clonal lymphocytes are detectable in only some cases of MDS. Br J Haematol 81:346-352, 1992.
4. Farr CJ, Saiki RK, Erlich HA, McCormick F, Marshall CJ: Analysis of Ras gene mutations in acute myeloid leukaemia by polymerase chain reaction and oligonucleatide probes. Proc Natl Clin Sci USA 85:1629-1633, 1988.
5. Franzin F, Efremov DG, Pozzatto G, et al: Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 90:548-552, 1995.
6. Gillespie WJ, Frampton CMA, Henderson RJ, Ryan PM: The incidence of cancer following total hip replacement. J Bone Joint Surg 70B:539-542, 1988.
7. Gibbs AR. Wagner JC: Environmental Pathology. In McGee JO'D, Issacson PG, Wright NA (ed.) Oxford Textbook of Pathology. Oxford, Oxford Medical Publications 721-778, 1992.
8. Goodfellow J: Editorial. Malignancy and joint replacement. J Bone Joint Surg 74B:645, 1992.
9. Heim S, Mitelman F: Cancer Cytogenetics. New York, Alan R Liss Inc 1987.
10. Hyodo K, Suzuki S, Furuya N, Meshizuka K: An analysis of chromium, copper and zinc in organs of a chromium worker. Int Arch Occup Environ Health 46:141-150, 1980.
11. International Agency for Research on Cancer Monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity. An updating of IARC Monographs Volumes 1 to 42, Supplement 7. WHO 1987.
12. International Agency for Research on Cancer Monographs on the evaluation of carcinogenic risks to humans. Chromium Nickel and Welding. Volume 49. WHO 1990.
13. Kawanishi S: Role of Active Oxygen Species in Metal-Induced DNA Damage. In Ballator B, Goyer RA, Cherin MG (eds). Toxicology of Metals. Biochemical Aspects. Springer, Hand Exp Pharm 49:349-371, 1995.
14. Lalor PA, Revell PA, Gray AP: Sensitivity to titanium: A cause of implant failure? J Bone Joint Surg 73B:25-28, 1991.
15. Langkamer VG, Case CP, Heap P, et al: Systemic distribution of wear debris after hip replacement: A cause for concern? J Bone Joint Surg 74B:831-839, 1992.
16. Mathiesen EB, Ahlbom A, Bermann G, Lindgren JU: Total hip replacement and cancer. A cohort study. J Bone Joint Surg 77B:345-350, 1995.
17. McCarthy KP, Sloane JP, Kabarowski JHS, Matute SE, Wiedemann LM: A simplified method of detection of clonal rearrangements of the T-cell receptor-Γ chain gene. Diagn Molec Pathol 3:173-179, 1992.
18. Memoli VA, Urban R, Alroy J, Galante JO: Malignant neoplasms associated with orthopaedic implant materials in rats. J Orthop Res 4:346-355, 1986.
19. Nyren O, McGlauglin JK, Gridley G, et al: Cancer risk after hip replacement with metal implants: A population-based cohort study in Sweden. J Natl Cancer Inst 87:28-33, 1995.
20. Perry P, Wolff S: New Giensa method for differential staining of sister chromatids. Nature 251:156, 1974.
21. Potter M, Steward CG, Oakhill A: The significance of the detection of minimal residual disease in childhood acute lymphoblastic leukaemia. Br J Haematol 83:412-418, 1993.
22. Ramasamy IB, Brisco M, Morley A: Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B Cell neoplasms. J Clin Pathol 45:770-775, 1992.
23. Rossman TG: Metal Metagenesis. In Ballator B, Goyer RA, Cherian MG (eds). Toxicology of Metals. Biochemical Aspects. Springer, Hand Exp Pharm 49:373-395, 1995.
24. Savage JRK: Classification and relationships of induced chromosomal structural changes. J Med Genet 12:103-122, 1995.
25. Seiler HG, Sigel A, Sigel H (eds): Handbook of Metals in Clinical and Analytical Chemistry, New York, Marcel Dekker 1994.
26. Steward CG, Goulder NJ, Katz F, et al: A polymerase chain reacion study of the stability of Ig heavy-chain and T-Cell receptor γ gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukaemia. Blood 83:1355-1662, 1994.
27. Suzuki Y, Orita M, Shiraishi I: Detection of ras gene mutations in human lung cancers by single strand conformation polymorphism analysis of polymeric chain reaction products. Oncogene 5:1037-1043, 1990.
28. Takamura K, Hayashi K, Ishinishi N, Yamada T, Sugioka: Evaluation of carcinogenicity and chronic toxicity associated with orthopaedic implants in mice. J Biomed Mater Res 28:583-589, 1994.
29. Talmud P, Tybjaerg-Hansen A, Bhatnaser D, et al: Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis 89:137-141, 1991.
30. Tawn EJ, Holdsworth D: Mutagen Induced Chromosome Damage in Human Lymphocytes, In Rooney DE, Czepulkowski B (eds). Human Cytogenetics, A Practical Approach. Vol 2. Malignancy and Acquired Abnormalities. Oxford, IRL Press 189-108, 1992.
31. Tsuneta Y, Ohsaki Y, Kimura K: Chromium content of lungs of chromate workers with Jung cancer. Thorax 35:294-297, 1980.
32. Visuri T, Koskenvuo M: Cancer risk after McKee-Farrar total hip replacement. Orthopedics 137-142, 1991.
33. Yunis JJ, Boot AJM, Mayar MG, Bos JL: Mechanisms of ras mutation in myelodysplastic syndrome. Oncogene 4:609-614, 1989.